Characterizing Self‐Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia
Laryngoscope Investigative Otolaryngology · 2026-04 · 11 (2)
DOI: 10.1002/lio2.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngoscope Investigative Otolaryngology, online erschienen am 26.02.2026. Verfasst von C M Tarulli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Toronto HHT Centre, Division of Respirology, Department of Medicine St. Michael's Hospital Toronto Ontario Canada. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Defense, University of Toronto.
Abstract (Originalsprache)
Objectives
To characterize a proposed clinical trial outcome measure of weekly cumulative bleeding duration from daily nosebleed diaries, termed PRO‐CB (patient‐reported outcome of cumulative bleeding). We also assessed cumulative weekly gushing bleeding duration (PRO‐CGB) and evaluated the accuracy of patient recall on Epistaxis Severity Score (ESS) items 1–3 compared with daily diary data.
Methods
In this prospective observational study at the Toronto HHT Centre (St. Michael's Hospital, Unity Health Toronto), 23 patients from two clinical trials were observed during three‐month run‐in periods. Participants recorded each nosebleed episode daily, noting duration and intensity (gushing vs. non‐gushing). Data were analyzed using linear mixed‐effects models, correlation tests, and partial autocorrelation analyses.
Results
Diary compliance was 98.8%. Mean weekly PRO‐CB was 71.2 min (SD 81.1); mean episode duration was 5.9 min (SD 12.6). Daily and monthly means were 10.1 min (SD 20.1) and 307.6 min (SD 311.6), respectively. Gushing episodes lasted significantly longer than non‐gushing (mean difference: 5.81 min; 95% CI: 4.53–7.09). Bleeding patterns varied widely across individuals. PRO‐CGB also showed inter‐patient variability. PRO‐CB and ESS total scores were not significantly correlated ( p = 0.18, r = 0.39). ESS items 1 and 2 correlated strongly with diary data ( p < 0.001); item 3 did not. Agreement was 83% for item 1% and 70% for items 2 and 3.
Conclusion
Daily nosebleed diaries are a feasible and accurate tool for tracking epistaxis severity in HHT. Despite inter‐patient variability, PRO‐CB offers a meaningful outcome measure for epistaxis clinical trials. Level of Evidence 2
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Toronto HHT Centre, Division of Respirology, Department of Medicine St. Michael's Hospital Toronto Ontario Canada.
- MAP Centre for Urban Health Solutions Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto Ontario Canada.
- Division of General Internal Medicine St. Michael's Hospital Toronto Ontario Canada.
- Department of Medicine University of Toronto Toronto Ontario Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto Toronto Ontario Canada.
- ICES Toronto Ontario Canada.
ORCID-Profile: C M Tarulli
Förderung
- U.S. Department of Defense
- University of Toronto
Zitieren
APA
Tarulli, C. M., Ma, X., Bayoumi, A. M., Patel, A., Vozoris, N. T., Lee, J. M., & Faughnan, M. E. (2026). Characterizing Self‐Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia. Laryngoscope Investigative Otolaryngology, 11(2). https://doi.org/10.1002/lio2.70354
Vancouver
Tarulli CM, Ma X, Bayoumi AM, Patel A, Vozoris NT, Lee JM, et al. Characterizing Self‐Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia. Laryngoscope Investigative Otolaryngology. 2026;11(2). doi:10.1002/lio2.70354
BibTeX
@article{Tarulli2026,
author = {Tarulli, C M and Ma, X and Bayoumi, A M and Patel, A and Vozoris, N T and Lee, J M and Faughnan, M E},
title = {Characterizing Self‐Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia},
journal = {Laryngoscope Investigative Otolaryngology},
year = {2026},
volume = {11},
number = {2},
doi = {10.1002/lio2.70354}
}
EUVIMED